PatentsGlobal
Maravai LifeSciences Expands mRNA and Oligonucleotide Capabilities with Acquisition of Molecular Assemblies’ IP and Assets
Maravai LifeSciences has acquired intellectual property and key assets from Molecular Assemblies, incorporating their proprietary enzymatic DNA synthesis platform into TriLink BioTechnologies. This strategic move aims to advance mRNA and CRISPR nucleic acid-based therapeutic development by improving oligonucleotide le…
Wednesday, January 29, 2025